Join to View Full Profile
13220 USF Laurel Dr, Tampa, FL 33612Tampa, FL 33612
Phone+1 813-974-9413
Fax+1 813-974-7138
Dr. Vu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York-Presbyterian HospitalPost-Doctoral Fellowship, 1994 - 1996- New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuromuscular Medicine (Neurology), 1993 - 1994
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1990 - 1993
Penn State Milton S Hershey Medical CenterInternship, Internal Medicine, 1989 - 1990
Pennsylvania State University College of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 2010 - 2028
PA State Medical License 1989 - 2010
NJ State Medical License 1994 - 2003
NY State Medical License 1992 - 2002
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
American Board of Electrodiagnostic MedicineFellow
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2012, 2014-2015, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014-2015, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2015, 2017
Clinical Trials
- Phase 3 Study of Dexpramipexole in ALS Start of enrollment: 2011 Mar 01
- The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis Start of enrollment: 2011 Jan 01
- Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Publications & Presentations
PubMed
- Burden of glucocorticoid use in commercially insured adults with generalized myasthenia gravis in the United States: A retrospective claims-based analysis.Nicholas J Silvestri, Jenny Y Park, Elizabeth Serra, Patrick Gagnon-Sanschagrin, Annie Guérin
Medicine. 2026-03-20 - 2 citationsImpact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network.Cynthia Z Qi, Yilu Lin, Yuebing Li, Tuan Vu, Deborah Gelinas
Journal of the Neurological Sciences. 2026-02-15 - 5 citationsDurability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis.Nizar Chahin, Gregory Sahagian, Marc H Feinberg, C Andrew Stewart, Christopher M Jewell
Annals of Clinical and Translational Neurology. 2025-11-01
Journal Articles
- Terminal Complement Inhibitory Ravulizumab in Generalized Myasthenia Gravis.Tuan Vu, M.D.,1 Andreas Meisel, M.D.,2 Renato Mantegazza, M.D.,3 Djillali Annane, M.D.,4 Masahisa Katsuno, M.D.,5 Rasha Aguzzi, M.S.,6 Ahmed Enayetallah, M.D., Ph.D.,6..., NEJM Evidence 1 (5). April 2022., 4/2022
Press Mentions
Cartesian Therapeutics Expands Clinical Advisory Board with Five Internationally Recognized Experts in AutoimmunityMarch 28th, 2023
Grant Support
- Mitochondrial DNA Depletion In Hepatoneural SyndromesNational Institute Of Neurological Disorders And Stroke2001
- Mitochondrial DNA Depletion In Human DiseaseNational Institute Of Neurological Disorders And Stroke1996–2000
Professional Memberships
- Member
Other Languages
- Vietnamese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
